Salud financiera de hoja de balance de WOOJUNG BIO
Salud financiera controles de criterios 0/6
WOOJUNG BIO has a total shareholder equity of ₩25.5B and total debt of ₩48.4B, which brings its debt-to-equity ratio to 190.1%. Its total assets and total liabilities are ₩91.2B and ₩65.7B respectively.
Información clave
190.1%
Ratio deuda-patrimonio
₩48.41b
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | ₩2.93b |
| Patrimonio | ₩25.47b |
| Total pasivo | ₩65.74b |
| Activos totales | ₩91.21b |
Actualizaciones recientes sobre salud financiera
Recent updates
Why Investors Shouldn't Be Surprised By WOOJUNG BIO, Inc.'s (KOSDAQ:215380) 30% Share Price Plunge
Oct 14
WOOJUNG BIO, Inc.'s (KOSDAQ:215380) Shares Bounce 43% But Its Business Still Trails The Industry
Aug 16Revenues Working Against WOOJUNG BIO, Inc.'s (KOSDAQ:215380) Share Price Following 26% Dive
Jun 14Is WOOJUNG BIO (KOSDAQ:215380) Weighed On By Its Debt Load?
May 23Análisis de la situación financiera
Pasivos a corto plazo: A215380's short term assets (₩14.7B) do not cover its short term liabilities (₩35.8B).
Pasivo a largo plazo: A215380's short term assets (₩14.7B) do not cover its long term liabilities (₩30.0B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: A215380's net debt to equity ratio (178.6%) is considered high.
Reducción de la deuda: A215380's debt to equity ratio has increased from 47% to 190.1% over the past 5 years.
Cobertura de la deuda: A215380's debt is not well covered by operating cash flow (3.2%).
Cobertura de intereses: Insufficient data to determine if A215380's interest payments on its debt are well covered by EBIT.